The Discounted Cash Flow (DCF) valuation of Clinica Baviera SA (CBAV.MC) is 50.95 EUR. With the latest stock price at 38.00 EUR, the upside of Clinica Baviera SA based on DCF is 34.1%.
Based on the latest price of 38.00 EUR and our DCF valuation, Clinica Baviera SA (CBAV.MC) is a buy. buying CBAV.MC stocks now will result in a potential gain of 34.1%.
| Range | Selected | |
| WACC / Discount Rate | 6.4% - 8.4% | 7.4% |
| Long-term Growth Rate | 0.5% - 1.5% | 1.0% |
| Fair Price | 41.37 - 66.31 | 50.95 |
| Upside | 8.9% - 74.5% | 34.1% |